ProfileGDS5678 / 1455364_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 113.8071100
GSM967853U87-EV human glioblastoma xenograft - Control 214.0306100
GSM967854U87-EV human glioblastoma xenograft - Control 314.0479100
GSM967855U87-EV human glioblastoma xenograft - Control 413.6833100
GSM967856U87-EV human glioblastoma xenograft - Control 514.1111100
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 114.0922100
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 213.8659100
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 313.9539100
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 413.8835100
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 113.8799100
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 213.8416100
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 314.0344100
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 413.9374100
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 514.0886100